SEC Company Response from IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Jul 20, 2005
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: July 20, 2005 · CIK: 0001326205 · Accession: 0000950137-05-008879
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-124942
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance Re: India Globalization Capital, Inc. (“Issuer”) Registration Statement No. 333-124942
Dear Mr. Reynolds:
At the request of Securities Commissioner of the Maryland Securities Division, we would like to inform you that the Issuer is requesting withdrawal of its application for registration in the State of Maryland.
If you have any questions about any of the foregoing, please contact the undersigned. Thank you.
Very truly yours,
/s/ Peter J. Bilfield
Show Raw Text
CORRESP
1
filename1.htm
corresp
600 LEXINGTON AVENUE
NEW YORK NY 10022-6018
T: 212-752-9700
F: 212-980-5192
INFO@GSKNY.COM
WWW.GSKNY.COM
July 20, 2005
VIA EDGAR
Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn:
John Reynolds
Assistant Director
Division of Corporation Finance
Re:
India Globalization Capital, Inc. (“Issuer”)
Registration Statement No. 333-124942
Dear Mr. Reynolds:
At the request of Securities Commissioner of the Maryland Securities Division, we would like
to inform you that the Issuer is requesting withdrawal of its application for registration in the
State of Maryland.
If you have any questions about any of the foregoing, please contact the undersigned. Thank
you.
Very truly yours,
/s/ Peter J. Bilfield
Peter J. Bilfield
AFFILIATED
WITH WHITEMAN OSTERMAN & HANNA LLP | ONE COMMERCE PLAZA
| ALBANY NY 12260 | T: 518-487-7600 F: 518-487-7777 |
WWW.WOH.COM